Status:
COMPLETED
Methods of Determining Asthma Severity in Children
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Asthma
Eligibility:
All Genders
6-17 years
Brief Summary
Current methods of measuring asthma severity can be problematic when used with children. A measurement called exhaled breath condensates (EBC) may be a more useful way to determine asthma severity in ...
Detailed Description
The current national guidelines for assessing asthma severity have several limitations for use in asthmatic children. One major limitation is that spirometric measures of airflow limitation, including...
Eligibility Criteria
Inclusion
- Inclusion Criteria for All Participants:
- Physician-diagnosed asthma
- Symptoms consistent with persistent asthma in the year prior to study entry
- Able to speak and understand English
- Parent or guardian willing to provide informed consent
- Exclusion Criteria for All Participants:
- Diagnoses indicating other lung-related disorders (e.g., cystic fibrosis, bronchopulmonary dysplasia \[BPD\])
- Allergy to latex
- Smoker
- Albuterol use within 12 hours of study entry
- Long-acting bronchodilator or leukotriene modifier use within 24 hours of study entry
- Unable to use the R-Tube. More information on this criterion can be found in the DAIT ICAC-EBC protocol.
- Exclusion Criteria for Part A Participants:
- ICS or oral corticosteroid use in the month prior to study entry
Exclusion
Key Trial Info
Start Date :
November 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2004
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00132834
Start Date
November 1 2003
End Date
March 1 2004
Last Update
January 25 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.